Personalized treatment for septic shock using vasopressors
Personalized vasopressor therapy in patients with septic shock
This study is looking at how different people with septic shock respond to blood pressure medications, using smart technology to create personalized tools that help doctors choose the best treatment for each patient to improve their chances of recovery.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10914810 on NIH RePORTER |
What this research studies
This research focuses on improving the treatment of septic shock, a severe condition with a high mortality rate. It aims to understand how individual patient characteristics affect their response to vasopressor medications, which are critical for managing blood pressure in these patients. By utilizing machine learning techniques, the project seeks to develop personalized tools that can predict how well a patient will respond to different vasopressors, ultimately aiming to enhance treatment outcomes. The research will also explore how to effectively implement these predictive models in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with septic shock who require vasopressor therapy.
Not a fit: Patients who do not have septic shock or those who are not candidates for vasopressor therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and tailored vasopressor therapies for patients with septic shock, potentially reducing mortality rates.
How similar studies have performed: Other research has shown promise in using personalized medicine approaches for critical care, suggesting that this innovative method could lead to significant advancements.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Bauer, Seth — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Bauer, Seth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.